Real-World Evidence Group Looks to Clear “NEST 2.0” Milestone

article image

The National Evaluation System for health Technology Coordinating Center is accelerating efforts toward its vision of “NEST 2.0,” which will be the demonstration of a fully functioning real-world evidence system to support regulatory decision-making. NESTcc head Sandra Siami tells Market Pathways her goal is to reach that critical juncture within the year.

Real-world evidence (RWE) is playing an increasingly prominent role in the medtech arena. Registries, for instance, are commonplace in monitoring device safety and performance. RWE has also started to become a factor in premarket regulatory submissions, for both new products and labeling expansions. But the practice of leveraging registries, electronic health records (EHRs), and other tools that generate real-world data (RWD) to support regulatory decision-making is still very much in its infancy.


This article is restricted to subscribers only.

Sign in to continue reading.


We're here to help! Please contact us at: